Silimar

General characteristics. Structure:

Active вещество:силимар® extract dry (thistles extract dry) with the maintenance of the sum of flavolignan in terms of Silubinum and absolutely dry matter of 65%. – 0,100 g.

Excipients: (sugar milk (lactose), potato starch, magnesium stearate. – enough before receiving a tablet weighing 0,2 g.

Pharmacological properties:

The main Silimara® active ingredients are the flavolignana received from fruits of a thistle of spotty Silybum marianum (L.) Gaerth. this. astrovy – Asteraceae.
Drug possesses gepatoprotektivny and anti-toxic action. The medical effect is caused by impact on metabolism of hepatocytes. Activates protein synthesis and enzymes in hepatocytes, makes the stabilizing impact on a membrane of hepatocytes, slows down penetration of toxins into liver cells, inhibits dystrophic and exponentiates regenerative processes of a liver.

Indications to use:

Силимар® accept at toxic injuries of a liver, chronic hepatitis, cirrhosis (as a part of complex therapy), after the postponed hepatitis. Preventively apply at chronic intoxications (including professional), long drug intake and alcohol.

Route of administration and doses:

Apply at adults and children 12 years inside on 1-2 tablets 3 times a day in 30 minutes prior to food are more senior. Course of treatment of 25-30 days. At chronic diseases repeated courses of treatment in 1-3 months are reasonable. In the preventive purposes of Silimar® it is recommended to accept at chronic intoxications (including professional), long drug intake and alcohol.

Features of use:

It is not recommended to use drug during pregnancy, to a lactation and children up to 12 years.

Side effects:

Allergic reactions, in some cases aperient action are possible.

Interaction with other medicines:

Data on medicinal interaction of drug Silimar are not provided.

Contraindications:

Individual intolerance.

Overdose:

Data on drug overdose Silimar are not provided.

Storage conditions:

In the dry, protected from light place at a temperature not above 25 °C.
To store in the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

Tablets on 100 mg. On 10, 30, 50 tablets in blister strip packagings. 3 blister strip packagings No. 10 or on one blister strip packaging No. 30 or No. 50 together with the application instruction place in a pack from a cardboard.